Page 64 - ITPS-8-1
P. 64

INNOSC Theranostics and
            Pharmacological Sciences                                               Opioid use among Nigerian students



               doi: 10.58729/1941-6687.1106                       doi: 10.1503/cmaj.109-4085
            52.  Ebigbo PO, Elekwachi CL, Nweze CF. Challenges in the   63.  Martins S, Fenton M, Keyes K, Blanco C, Zhu H, Storr C.
               treatment of drug misuse in a Nigerian female health worker:   Mood and anxiety disorders and their association with non-
               A  case study applying the Wawa technique.  J  Contemp   medical prescription opioid use and prescription opioid-
               Psychother. 2012;42(4):257-264.                    use  disorder:  longitudinal  evidence from the  national
               doi: 10.1007/s10879-012-9213-9                     epidemiologic study on alcohol and related conditions.
                                                                  Psychol Med. 2011;42(6):1261-1272.
            53.  Molobe ID. Human rights misuse experienced by people
               who use drugs. A Nigeria-focused review. Int J Med Surg Sci.      doi: 10.1017/s0033291711002145
               2019;6(4):133-135.                              64.  Gilson A, Maurer M, Ryan K, Rathouz P, Cleary J. Using
               doi: 10.32457/ijmss.2019.039                       a morphine equivalence metric to quantify opioid
                                                                  consumption: Examining the capacity to provide effective
            54.  NAFDAC  -  National Agency for Food and Drugs    treatment of debilitating pain at the global, regional, and
               Administration and Control. Available from: https://www.  country levels. J Pain Symptom Manag. 2013;45(4):681-700.
               nafdac.gov.ng [Last accessed on 2024 Apr 10].
                                                                  doi: 10.1016/j.jpainsymman.2012.03.011
            55.  National  Drug  Law  Enforcement  Agency.  Available
               from: https://www.ndlea.gov.ng/about [Last accessed on   65.  McCabe S, West B, Boyd C. Leftover prescription opioids
               2024 Apr 10].                                      and nonmedical use among high school seniors: A multi-
                                                                  cohort national study. J Adolesc Health. 2013;52(4):480-485.
            56.  Donnelly J, Saldutti E, Gavin L, Hecht M. Public health
               implications: A  scoping review of opioid prevention      doi: 10.1016/j.jadohealth.2012.08.007
               programs among adolescents. Med Res Arch. 2023;11:72.
                                                               66.  Evans R, Widman L, Javidi H, et al. Preliminary evaluation
               doi: 10.18103/MRA.v11i7.2.4153                     of  a prescription  opioid misuse prevention program
                                                                  among rural middle school students.  J  Commun Health.
            57.  Pius S. Drug misuse and health implication for the Nigerian
               federation of catholic students (secondary school and   2020;45(6):1139-1148.
               university) in  Maiduguri  diocese “for lent  season”.  Afr J      doi: 10.1007/s10900-020-00899-5
               Psychol Stud Soc Issues. 2017;20:8.
                                                               67.  McCabe  S,  West  B,  Boyd  C.  Motives  for  medical  misuse
            58.  McElrath K, Joseph H. Medication-assisted treatment   of prescription opioids among adolescents.  J  Pain.
               (MAT) for opioid use disorder: Introduction to the special   2013;14(10):1208-1216.
               issue. Substitute Misuse. 2018;53(2):177-180.
                                                                  doi: 10.1016/j.jpain.2013.05.004
               doi: 10.1080/10826084.2017.1404106
                                                               68.  Hall E, Cernasev A, Nasritdinova U, Veve M. The stigma
            59.  Miles J, Howell J, Sheridan D, Braucht G, Mericle A.   of opioid use disorder and its indirect effects on student
               Supporting individuals using medications for opioid   pharmacists’ perceptions and attitudes.  Pharmacy.
               use  disorder  in recovery  residences:  Challenges and   2020;8(3):144.
               opportunities for addressing the opioid epidemic.  Am J
               Drug Alcohol Misuse. 2020;46(3):266-272.           doi: 10.3390/pharmacy8030144
               doi: 10.1080/00952990.2020.1719410              69.  Cepeda M, Coplan P, Kopper N, Mazière J, Wedin G,
                                                                  Wallace L. Er/la opioid analgesics rems: An overview of
            60.  Bauder MA. Barriers to rural treatment of opioid use disorder   ongoing assessments of its progress and its impact on health
               and alcoholism. J Alcohol Drug Depend. 2018;6(4):318.  outcomes. Pain Med. 2016;18(1):78-85.
               doi: 10.4172/2329-6488.1000318                     doi: 10.1093/pm/pnw129
            61.  Tarter RE, Cochran G, Reynolds M. Prevention of opioid   70.  McCabe S, Veliz P, Schulenberg J. Adolescent context of
               use disorder. Commonwealth. 2018;20(2-3):39-60.    exposure to prescription opioids and substance use disorder
               doi: 10.15367/com.v20i2-3.187                      symptoms at age 35: A  national longitudinal study.  Pain.
                                                                  2016;157(10):2173-2178.
            62.  Webster PC. Tracking opioid use is vital to avoiding the
               scourge. Can Med Assoc J. 2012;184(2):E129-E130.     doi: 10.1097/j.pain.0000000000000624












            Volume 8 Issue 1 (2025)                         58                               doi: 10.36922/itps.3894
   59   60   61   62   63   64   65   66   67   68   69